Table 4 Distribution of feline hemoplasma infection in client-owned cats in accordance with different haematological findings, and the presence or absence of clinical signs
From: Epidemiological study of hemotropic mycoplasmas (hemoplasmas) in cats from central Spain
Variable | Total no. of cats (%) | Number of positive cats (%) | ||||||
|---|---|---|---|---|---|---|---|---|
Any hemoplasmas | Mhf | CMhm | CMt | Mhf + CMhm | CMt + CMhm | CMt + Mhf | ||
456 | 41 (9.0) | 10 (3.2) | 36 (7.9) | 2 (0.4) | 5 (1.1) | 1 (0.2) | 1 (0.2) | |
Clinical signs | 425 | |||||||
Yes | 325 (76.5) | 29 (8.9) | 8 (2.5) | 24 (7.4) | 1 (0.3) | 3 (0.9) | 0 | 1 (0.3) |
No | 100 (23.5) | 5 (5.0) | 1 (1.0) | 5 (5.0) | 0 | 1 (1.0) | 0 | 0 |
Coronavirus seropositivity | 304 | |||||||
Yes | 10 (3.3) | 1 (10.0) | 1 (10.0) | 1 (10.0) | 0 | 1 (10.0) | 0 | 0 |
No | 294 (96.7) | 24 (8.2) | 6 (2.0) | 21 (7.1) | 1 (0.3) | 3 (1.0) | 0 | 1 (0.3) |
Haematology | ||||||||
RBC (× 106 μl) | 331 | |||||||
High (> 10) | 60 (18.1) | 4 (6.7) | 0 | 4 (6.7) | 0 | 0 | 0 | 0 |
Normal (5–10) | 251 (75.8) | 23 (9.2) | 3 (1.2) | 21 (8.4) | 2 (0.8) | 1 (0.4) | 1 (0.4) | 1 (0.4) |
Low (< 5) | 20 (6.0) | 6 (30.0)* | 2 (10.0)* | 5 (25)* | 0 | 1 (5.0) | 0 | 0 |
HGB (g/dl) | 407 | |||||||
High (> 15) | 16 (3.9) | 1 (6.2) | 0 | 1 (6.2) | 0 | 1 (6.2) | 0 | 0 |
Normal (9–15) | 332 (81.6) | 26 (7.8) | 6 (1.8) | 23 (6.9) | 2 (0.6) | 3 (0.9) | 0 | 1 (0.3) |
Low (< 9) | 59 (14.5) | 12 (20.3)* | 2 (3.4) | 11 (18.6)* | 0 | 0 | 1 (1.7) | 0 |
Haematocrit (%) | 410 | |||||||
High (> 45) | 22 (5.4) | 1 (4.5) | 0 | 1 (4.5) | 0 | 0 | 0 | 0 |
Normal (24–45) | 360 (87.8) | 32 (8.9) | 6 (1.7) | 29 (8.1) | 2 (0.6) | 3 (0.8) | 1 (0.3) | 1 (0.3) |
Low (< 24) | 28 (6.8) | 6 (21.4)* | 2 (7.1) | 5 (17.9) | 0 | 1 (3.6) | 0 | 0 |
MCV (fl) | 333 | |||||||
High (> 55) | 5 (1.5) | 2 (40.0) | 1 (20.0) | 1 (20.0) | 1 (20.0) | 0 | 1 (20.0) | 0 |
Normal (39–55) | 252 (75.7) | 25 (9.9) | 4 (1.6) | 23 (9.1) | 1 (0.4) | 2 (0.8) | 0 | 1 (0.4) |
Low (< 39) | 76 (22.8) | 4 (7.9) | 0 | 6 (7.9) | 0 | 0 | 0 | 0 |
MCH (pg) | 335 | |||||||
High (> 17.5) | 7 (2.1) | 2 (28.6) | 1 (12.5) | 1 (14.3) | 1 (12.5) | 0 | 1 (12.5) | 0 |
Normal (12.5–17.5) | 273 (81.5) | 27 (9.9) | 3 (1.1) | 25 (9.2) | 1 (0.4) | 1 (0.4) | 0 | 1 (0.4) |
Low (< 12.5) | 55 (16.4) | 4 (7.3) | 1 (1.8) | 4 (7.3) | 0 | 1 (1.8) | 0 | 0 |
MCHC (g/dl) | 405 | |||||||
High (> 36) | 10 (2.5) | 2 (20.0) | 1 (10.0) | 1 (10.0) | 1 (10.0) | 0 | 0 | 1 (10.0) |
Normal (30–36) | 381 (94.1) | 36 (9.4) | 6 (1.6) | 34 (8.9) | 1 (0.3) | 4 (1.0) | 1 (0.3) | 0 |
Low (< 30) | 14 (3.5) | 1 (7.1) | 1 (7.1) | 0 | 0 | 0 | 0 | 0 |
Leukocytes (× 103 μl) | 408 | |||||||
High (> 14) | 77 (18.9) | 5 (6.5) | 1 (1.3) | 5 (6.5) | 0 | 1 (1.3) | 0 | 0 |
Normal (5.5–14) | 273 (66.9) | 29 (10.6) | 7 (2.6) | 25 (9.2) | 2 (0.7) | 3 (1.1) | 1 (0.4) | 1 (0.4) |
Low (< 5.5) | 58 (14.2) | 5 (8.6) | 0 | 5 (8.6) | 0 | 0 | 0 | 0 |
Platelets (× 103 μl) | 148 | |||||||
High (> 800) | 12 (8.1) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Normal (800–300) | 60 (40.5) | 6 (10.0) | 3 (5.0) | 5 (8.3) | 0 | 2 (3.3) | 0 | 0 |
Low (< 300) | 76 (51.3) | 7 (9.2) | 1 (1.3) | 7 (9.2) | 0 | 1 (1.3) | 0 | 0 |